Well , I was here when this was happening , first I learned
Well , I was here when this was happening , first I learned about it from our CC ,
And during one of the conference Dr Patterson was explaining that CCR5 expression we may see on tumor itself , in the surrounding tumor microenvironment , or in both areas , and all those patients should respond to CCR5 inhibitors .
After that , I don't know from where , possibly also from Dr Patterson we learned the very first patient Dr Pestell removed from the study after her final biopsy results came , her CCR5 expression was only on the micrornvironment , but not on the tumor ..
Then I read more about , did some research , and Dr Patterson is correct.. .
You may listen to the CCs from 2019-2020 , you may research internet , or even call Dr Patterson , I feel he will be happy to talk with you about it.
11
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Breaking Barriers in Quantum Emulation If you think the quantum computing game is all about hardware, then you're missing half the picture. Enter BTQ Technologies, crash-landing into the scene by throwing open the doors of their MIMIQ emulator to a crowd of over 35,000 quantum developers through qBraid. This ain't just an upgrade—it's a seismic shift. More qubits, more...
Continue Reading
SoftwareOne Nabs Prestigious GitHub Honor Outta nowhere, SoftwareOne's been lashed onto the center stage, bagging GitHub's Global Channel Sales Partner of the Year for 2026. This ain't just another shiny trophy on the shelf; it's a solid nod to their grit and strategy. Now, if good old GitHub says you're their top dog, you're obviously doing something right. Not bad for a...
Continue Reading
Turning the Tide on Pharmacy Costs The world of pharmacy benefits is getting a long-overdue shake-up, courtesy of a new rule mandating transparency from the pharmacy benefit managers (PBMs). This ain't your everyday administrative tweak—it's a seismic shift for the 136 million Americans tied into employer-sponsored health plans. Thanks to the U.S. Department of Labor...
Continue Reading
Yale’s Inflammation Research: Beyond the Basics Inflammation. It’s the kind of battle your own body wages from within, and Yale School of Medicine’s fresh $10 million grant from the Blavatnik Family Foundation means they’re marching deeper into the trenches. This is not another academic exercise; it’s about digging out the roots of diseases that are tough to pin...
Continue Reading
Trading on the Go Takes a Leap Forward Pretty slick development from TIOmarkets, if I do say so myself. They've rolled out a major expansion of their mobile trading app, now packing some hefty features like Depth of Market and more granular order controls right from those little devices in our pockets. Quite the leap if you're one of those folks who can't keep your eyes...
Continue Reading
Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....
Continue Reading
Equitable Bank Dials Up Its Prime Rate Equitable Bank's taken a step that every borrower and investor out there can't ignore: they've hiked their prime lending rate by 25 basis points, pushing it up to 4.70% from 4.45%. Now, any old-timer in the trading arena knows that when banks shift their rates, it's not just numbers on paper—it ripples across the landscape, from...
Continue Reading
A Tumultuous Time for Beta Bionics Investors Trouble's brewing for those holding Beta Bionics, Inc. (NASDAQ: BBNX) shares. This isn't just market jitters—it's a full-blown legal tussle. The shareholder-rights law honchos at Johnson Fistel are sounding the alarms, and investors better heed their call before the clock strikes November 3, 2026. There's a class action...
Continue Reading
Bitcoin Meets Canadian Mortgages: A Game Changer? Here's a scenario you didn't see coming: Bitcoin, the digital darling of the new millennium, now backing Canadian mortgages. If that doesn't get your financial senses tingling, maybe you haven't been paying attention. APX Lending, a pioneer in digital-asset-backed lending, is kicking open the doors to a fresh financial...
Continue Reading
Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...
Continue Reading
Top 5 Most Recently Viewed Articles
Bullfrog AI's Financial Moves to Propel Future Growth BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) is setting the stage for substantial growth with its latest financial initiatives. WallachBeth Capital announced that the company has entered into a definitive agreement for the sale of approximately 1,565,000 shares of common stock through a registered direct offering....
Continue Reading
New Leadership in the UK Market Aclarion, Inc. is excited to announce the appointment of Dan Isherwood as the new UK Commercial Director. This strategic hire marks a significant milestone for the company, enhancing its capacity to penetrate the UK healthcare market effectively. With a robust background in HealthTech, Isherwood is poised to help drive the utilization of...
Continue Reading
Navigating Travel Insurance Amidst Potential Government Shutdowns As uncertainties loom regarding potential government shutdowns, travelers find themselves questioning how these events might disrupt their plans. A looming government shutdown often leads to numerous challenges, including staffing shortages at key agencies such as the FAA and TSA. These essential services,...
Continue Reading
Immuthera's Scientific Advisory Board: Innovation at the Forefront Immuthera, a leading name in the field of cell therapies, is thrilled to introduce its newly assembled Scientific Advisory Board. This esteemed group includes renowned experts like Dr. Jay Skyler, Dr. Desmond Schatz, and Dr. Lawrence Steinman. Their collective expertise will drive innovative solutions in...
Continue Reading
Astroport and Orbit Fab Team Up for Lunar Exploration Astroport Space Technologies, Inc., a leader in advanced space exploration solutions, and Orbit Fab, Inc., renowned for in-space refueling and resource utilization, have announced an exciting partnership aimed at accelerating lunar infrastructure development. This collaboration marks a pivotal moment in the quest for...
Continue Reading